Abstract: An organometallic compound represented by one of Formulae 1 to 4: wherein, in Formulae 1 to 4, groups and variables are the same as described in the specification.

Abstract: A crystalline form of ticagrelor, designated as Form-AM, has a defined interplanar spacing as illustrated by FIG. 1.

Abstract: An organometallic compound represented by Formula 1: wherein in Formula 1, R11 to R20, L11, m11, and n11 are the same as described in the specification.

Abstract: An organometallic compound represented by Formula 1: M(L1)n1(L2)n2??Formula 1 wherein in Formula 1, M, L1, L2, n1, and n2 are the same as described in the specification.

Abstract: Salts of eltrombopag are provided. Eltrombopag olamine is prepared from salts of eltrombopag, which are used as intermediates.

Abstract: The present invention provides a process for preparation of Vortioxetine hydrobromide (I). The present invention also relates to the novel intermediate and its use in preparation of vortioxetine hydrobromide (I).

Abstract: An organometallic compound represented by Formula 1: wherein in Formula 1, M, L1, n1, n2, and R41 to R47 are described in the specification.

Abstract: An organometallic compound represented by Formula 1: wherein, in Formula 1, groups and variables are the same as described in the specification.

Abstract: The present invention provides a cost effective and industrially feasible process for preparation of Darunavir (I). Also described is the novel salt of intermediate 4-Amino-N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isobutylbenzene sulfonamide acid salt (VIII) and its use in the preparation of Darunavir. Formula (I) and (VII).

Abstract: An organometallic compound represented by Formula 1: M(L1)n1(L2)n2??Formula 1 wherein in Formula 1, M, L1, L2, n1, and n2 are the same as described in the specification.

Abstract: An organometallic compound represented by one of Formulae 1A and 1B: wherein, in Formulae 1A and 1B, A11, b20, L11, M, m, n, and R15 to R20 are the same as described in the specification.

Abstract: An organometallic compound represented by Formula 1: wherein, in Formula 1, L11, M, R11 to R17, m, and n are the same as described in the specification.

Abstract: Described is an improved, industrially feasible and environmental friendly process for the preparation of Rivaroxaban. Also described are novel compounds which may be used as intermediates in preparation of Rivaroxaban.

Abstract: An organometallic compound represented by Formula 1: M(L1)n1(L2)n2??Formula 1 wherein in Formula 1, M, L1, L2, n1, and n2 are the same as described in the specification.

Abstract: The present invention relates to the development of a novel, morphologically and genetically distinct khusinol rich essential oil producing clone of vetiver [Vetiveria zizaniodes (L.) Nash. syn. Chrysopogon zizanioides (L.) Roberty; family Poacaeae} named ‘CIMAP-Khusinolika’. The plant of this clone is characterized by spreading type clump canopy in the initial stage, white feathery stigma and capable of producing >1% (v/w) essential oil containing 45-50% Khusinol (v/v) obtained after hydro-distillation from fresh roots harvested from 6 month old plantations. This clone has unique ISSR profiles that serve as DNA-fingerprints. The clone was obtained through recurrent selection in polycrossed population generated from the bulk of wild collection, and can be propagated through vegetative slips (3 to 6 month old stem with few roots) for commercial plantation as a short duration crop.

Abstract: Described is an improved and industrially feasible process for the preparation of Saxagliptin or its hydrochloride salt. Also described are the novel intermediates and their use in the preparation of Saxagliptin or its hydrochloride salt.

Abstract: An organometallic compound represented by Formula 1: wherein in Formula 1, R11 to R20, L11, m11, and n11 are the same as described in the specification.

Abstract: A garbled circuit is generated for a client in a leakage-resilient manner with a reduced memory requirement. The garbled circuit is used for secure function evaluation between the client and a server. The garbled circuit is generated with a reduced storage requirement by obtaining a token from the server; querying the token gate-by-gate, wherein for each gate of the garbled circuit, the token generates new wire garblings and stores them with the client using a Stream Cipher and interacts with the leakage-protected area to generate a garbled table for the gate; and receiving the garbled circuit from the token. The token comprises a leakage-protected area. The Stream Cipher is leakage-resilient and can be a symmetric-key cryptographic primitive that has a secret key as an input and generates an unbounded stream of pseudorandom bits as an output. The number of evaluations of the Stream Cipher is kept to a substantial minimum.

Abstract: Described is an improved and industrially feasible process for the preparation of Saxagliptin or its hydrochloride salt. Also described are the novel intermediates and their use in the preparation of Saxagliptin or its hydrochloride salt.

Abstract: The present invention relates to the development of a novel, morphologically and genetically distinct khusinol rich essential oil producing clone of vetiver [Vetiveria zizaniodes (L.) Nash. syn. Chrysopogon zizanioides (L.) Roberty; family Poacaeae} named ‘CIMAP-Khusinolika’. The plant of this clone is characterized by spreading type clump canopy in the initial stage, white feathery stigma and capable of producing >1% (v/w) essential oil containing 45-50% Khusinol (v/v) obtained after hydro-distillation from fresh roots harvested from 6 month old plantations. This clone has unique ISSR profiles that serve as DNA-fingerprints. The clone was obtained through recurrent selection in polycrossed population generated from the bulk of wild collection, and can be propagated through vegetative slips (3 to 6 month old stem with few roots) for commercial plantation as a short duration crop.